Plant-based vaccine production emerges as a promising frontier. Leveraging the natural capabilities of plants, this innovative approach offers a sustainable, efficient, and scalable alternative to traditional vaccine manufacturing methods. During the Effervescence Forum we were invited to last week in Montréal, we met with Frédéric Ors, CEO of Aramis Biotechnologies to learn more about this new type of “vegan” vaccine that is poised to transform the landscape of biomanufacturing. Interview.